Developer docs
API playgroundTry for free, no card

Search company profiles

Genemod

Full company profile

uuid00026xk

Namestring
Genemod
Legal namestring
Genemod, Inc.
Websiteurl
genemod.net
Company typeenum
Private
Founded yearint
2023
Descriptiontext

Genemod, Inc. is a Seattle-based, venture-backed private company that operates an AI-powered, cloud-based "Agentic Lab OS" combining Electronic Lab Notebook (ELN) and Laboratory Information Management System (LIMS) functionality in a single unified platform. The product spans inventory management (Virtual Freezers/Sample Management, Lineage, Lab Consumables, Orders, Alerts), notebook features (Experiments, Lab Protocols, Version Control, Reports), and a Genemod AI suite that includes an AI Agent capable of executing audit-logged, multi-step lab operations from a single natural-language prompt, plus AI Global Search, AI Sample Tracking, AI Protocol Template, AI Data Migration, AI Data Security, and AI-Driven Workflows. The underlying AI capabilities are built on GPT (third-party foundation model) and are designed for regulated environments managing 10M+ records, with built-in version control, audit trails, and SOC 2 Type II, HIPAA, and GDPR compliance certifications.

The platform targets life sciences R&D customers across biopharmaceutical companies, biotech startups, clinical research organizations, biorepositories, industrial biotech, biomanufacturers, contract services, academia, and diagnostics. Named enterprise and institutional users include Pfizer, Merck, Bristol Myers Squibb, AstraZeneca, Memorial Sloan Kettering, Johns Hopkins, Harvard, Stanford, Seattle Children's Research Institute, and Wisconsin State Laboratory of Hygiene, alongside biotech customers such as Antharis Therapeutics, Colossal Biosciences, Galileo, and RoverDx. The company pursues a hybrid go-to-market with a self-serve product-led growth (free signup) motion for smaller teams and startups, complemented by enterprise field sales (request-a-demo) for large pharma and research institutions.

Genemod has raised approximately $8.2 million in cumulative outside funding across three rounds (October 2020: $1.7M; August 2022: $2.0M; May 2023: $4.5M seed co-led by defy.vc and LDV Partners, with Vulcan Capital, Dolby Family Ventures, Futureland Ventures, and Looking Glass Capital participating). The company was founded by Jacob Lee (CEO) and Jin Choe (CTO). Revenue model is SaaS subscription with publicly undisclosed pricing described as "simple and predictable pricing that scales with your team," and no revenue figures are publicly disclosed.

Short descriptiontext

Genemod provides an AI-powered, cloud-based platform unifying Electronic Lab Notebook (ELN) and Laboratory Information Management System (LIMS) functionality with agentic AI for life sciences R&D. It serves pharmaceutical companies, biotech firms, academic research institutions, and clinical labs with SOC 2 Type II, HIPAA, and GDPR compliance.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSeattle, United States
HQ citystring
Seattle
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
lab information management, electronic lab notebook, lab inventory management, biopharma R&D software, agentic lab platform
Industry2 codes
PRIMARYHLAGAIAF
Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays)
SECONDARYHLAAAIAD
Synthetic Biology & Genetic Circuit Design Platforms (pathway engineering, chassis development)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
NAICS code2 codes
  • Scientific Research and Development Services5417
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code2 codes
  • Services-Prepackaged Software7372
  • Services-Commercial Physical & Biological Research8731
Product category
Lab Information Management and Electronic Lab Notebook Software
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1SaaS Subscription
TypeSubscription Recurring
Description

Cloud-based SaaS platform with subscription pricing model. Platform offers free signup option suggesting freemium or trial tiers, with enterprise pricing likely quote-based.

genemod.net
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Genemod provides an AI-powered cloud-based Lab OS that unifies an Electronic Lab Notebook (ELN) and a Laboratory Information Management System (LIMS) into a single platform for life sciences R&D teams. The product covers inventory and sample management, experiment and protocol documentation, order tracking, alerts, and equipment management, augmented by an agentic AI layer that executes real, audit-logged lab operations via natural language. It is sold as a SaaS subscription to pharmaceutical companies, biotech firms, clinical research organizations, biorepositories, academic institutions, and government labs.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 10x faster sample registration vs. manual click-through
+2 more records
Product overview1 text field

Genemod offers an Agentic Lab OS combining AI-powered LIMS (Laboratory Information Management System) and ELN (Electronic Lab Notebook) in one unified platform. The core portfolio includes AI LIMS, AI ELN, and AI Agent products, supplemented by AI features (Global Search, Sample Tracking, Protocol Template, Data Migration, Data Security, AI-Driven Workflows) all powered by the Genemod AI platform using GPT. Additional platform components include inventory management tools (Virtual Freezers/Sample Management, Lineage, Lab Consumables, Orders, Alerts), notebook features (Experiments, Lab Protocol, Version Control, Reports), and platform infrastructure (Security, Integrations, Equipment). The system is designed for regulated labs managing 10M+ records with built-in audit trails, compliance features, and cloud-based architecture for biopharma R&D teams.

Product and service4 records
1AI LIMS
CategoryLaboratory Information Management System (LIMS)
Description

AI-powered Laboratory Information Management System that transforms lab operations, streamlines workflows, and accelerates scientific discovery through integrated inventory, sample, and equipment management. Used by biopharma R&D teams, biotech startups, clinical research, biorepositories, and academic labs.

2AI ELN
CategoryElectronic Lab Notebook (ELN)
Description

AI-powered Electronic Lab Notebook with GPT integration for streamlined data access, enhanced research report quality, and experimental process optimization. Used by life sciences researchers and lab teams to capture and collaborate on experiments.

3AI Agent
CategoryAgentic AI Lab Automation
Description

Natural language AI agent that executes real, audit-logged actions across inventory and notebooks through conversational commands, covering sample registration (10x faster than manual), transfers, documentation, and protocol management. Targeted at regulated labs running complex multi-step operations.

4Genemod AI Platform
CategoryAI Platform
Description

Core AI platform powering all Genemod AI features, enabling GPT-based assistance within the LIMS/ELN environment for search, sample tracking, protocol templating, data migration, security, and AI-driven workflows.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Benchling is the leading cloud-native ELN and R&D platform for life sciences, directly competing with Genemod's AI LIMS and AI ELN products. Both target biopharma R&D teams with unified data models, audit trails, and AI-assisted workflows, making it Genemod's most direct competitor.

TypeDirect peer
Description

LabArchives is a widely adopted electronic lab notebook used across academia and industry. Genemod explicitly publishes a 'LabArchives vs Genemod' comparison page, confirming it as a direct competitor for ELN and lab data management in research labs.

3Quartzy
TypeDirect peer
Description

Quartzy is a lab inventory and order management platform that overlaps with Genemod's inventory, consumables, and order-tracking modules. Genemod publishes a 'Quartzy vs Genemod' comparison page, indicating direct competition for lab operations workflows.

TypeDirect peer
Description

Dotmatics (now part of Siemens) provides a scientific R&D platform with ELN, LIMS, and inventory capabilities targeting biopharma. It competes directly with Genemod across the same primary customer segments and core product modules.

TypeDirect peer
Description

IDBS offers the Polar and E-WorkBook ELN/LIMS platforms widely used in biopharma R&D and bioprocess development. It is a direct peer serving the same biopharma, industrial biotech, and CDMO customers that Genemod targets.

6Sapio Sciences
TypeDirect peer
Description

Sapio Sciences provides a unified LIMS, ELN, and scientific data management platform with growing AI capabilities. It serves biopharma and diagnostics customers comparable to Genemod's primary segments, with similar emphasis on regulated environments.

TypeDirect peer
Description

LabVantage is an enterprise LIMS platform with ELN extensions used by pharma, biobanks, and manufacturing. It competes for the same regulated lab data management budget as Genemod, particularly in biomanufacturing and biorepository use cases.

8FreezerPro (Brooks Life Sciences)
TypeDirect peer
Description

FreezerPro is a sample and freezer management solution used by biobanks and research labs. Genemod publishes a 'FreezerPro vs Genemod' comparison page, indicating direct overlap in virtual freezer, sample, and inventory workflows.

TypeBroad incumbent
Description

Revvity Signals offers the TIBCO Spotfire and Signals Notebook/Notebook+ products covering ELN, LIMS, and analytics for pharma and life sciences. It is a broad incumbent with overlapping capabilities rather than a niche specialist like Genemod.

TypeBroad incumbent
Description

STARLIMS is a long-standing LIMS platform used across clinical, manufacturing, and life sciences labs. It competes in the broader LIMS category but is a generalist incumbent rather than an AI-native, life-sciences-focused platform like Genemod.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers15 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment9 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability9 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors12 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Genemod

Lab Information Management and Electronic Lab Notebook Softwaregenemod.net

Genemod provides an AI-powered, cloud-based platform unifying Electronic Lab Notebook (ELN) and Laboratory Information Management System (LIMS) functionality with agentic AI for life sciences R&D. It serves pharmaceutical companies, biotech firms, academic research institutions, and clinical labs with SOC 2 Type II, HIPAA, and GDPR compliance.

What Genemod does

Genemod, Inc. is a Seattle-based, venture-backed private company that operates an AI-powered, cloud-based "Agentic Lab OS" combining Electronic Lab Notebook (ELN) and Laboratory Information Management System (LIMS) functionality in a single unified platform. The product spans inventory management (Virtual Freezers/Sample Management, Lineage, Lab Consumables, Orders, Alerts), notebook features (Experiments, Lab Protocols, Version Control, Reports), and a Genemod AI suite that includes an AI Agent capable of executing audit-logged, multi-step lab operations from a single natural-language prompt, plus AI Global Search, AI Sample Tracking, AI Protocol Template, AI Data Migration, AI Data Security, and AI-Driven Workflows. The underlying AI capabilities are built on GPT (third-party foundation model) and are designed for regulated environments managing 10M+ records, with built-in version control, audit trails, and SOC 2 Type II, HIPAA, and GDPR compliance certifications.

The platform targets life sciences R&D customers across biopharmaceutical companies, biotech startups, clinical research organizations, biorepositories, industrial biotech, biomanufacturers, contract services, academia, and diagnostics. Named enterprise and institutional users include Pfizer, Merck, Bristol Myers Squibb, AstraZeneca, Memorial Sloan Kettering, Johns Hopkins, Harvard, Stanford, Seattle Children's Research Institute, and Wisconsin State Laboratory of Hygiene, alongside biotech customers such as Antharis Therapeutics, Colossal Biosciences, Galileo, and RoverDx. The company pursues a hybrid go-to-market with a self-serve product-led growth (free signup) motion for smaller teams and startups, complemented by enterprise field sales (request-a-demo) for large pharma and research institutions.

Genemod has raised approximately $8.2 million in cumulative outside funding across three rounds (October 2020: $1.7M; August 2022: $2.0M; May 2023: $4.5M seed co-led by defy.vc and LDV Partners, with Vulcan Capital, Dolby Family Ventures, Futureland Ventures, and Looking Glass Capital participating). The company was founded by Jacob Lee (CEO) and Jin Choe (CTO). Revenue model is SaaS subscription with publicly undisclosed pricing described as "simple and predictable pricing that scales with your team," and no revenue figures are publicly disclosed.

Genemod firmographics

Firmographics
Name
Genemod
Legal name
Genemod, Inc.
Website
https://genemod.net
Company type
Private
Founded year
2023
Operating status
Operating
Headcount range
1–10 employees
Short description
Genemod provides an AI-powered, cloud-based platform unifying Electronic Lab Notebook (ELN) and Laboratory Information Management System (LIMS) functionality with agentic AI for life sciences R&D. It serves pharmaceutical companies, biotech firms, academic research institutions, and clinical labs with SOC 2 Type II, HIPAA, and GDPR compliance.
Ownership category
akta.pro rank

Genemod industry classification

Industry
Product category
Lab Information Management and Electronic Lab Notebook Software
NAICS
Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Prepackaged Software (7372), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAIAF
Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays)
SECONDARYHLAAAIAD
Synthetic Biology & Genetic Circuit Design Platforms (pathway engineering, chassis development)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)

Keywords

  • Lab information management
  • Electronic lab notebook
  • Lab inventory management
  • Biopharma R&D software
  • Agentic lab platform

Where Genemod is headquartered

Location

Headquarters

HQ city
Seattle
HQ country
United States
HQ region
North America

Markets served

Genemod business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations

Revenue model

  1. SaaS Subscription: Cloud-based SaaS platform with subscription pricing model. Platform offers free signup option suggesting freemium or trial tiers, with enterprise pricing likely quote-based.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Genemod product offering

Product offering

Core offering

Genemod provides an AI-powered cloud-based Lab OS that unifies an Electronic Lab Notebook (ELN) and a Laboratory Information Management System (LIMS) into a single platform for life sciences R&D teams. The product covers inventory and sample management, experiment and protocol documentation, order tracking, alerts, and equipment management, augmented by an agentic AI layer that executes real, audit-logged lab operations via natural language. It is sold as a SaaS subscription to pharmaceutical companies, biotech firms, clinical research organizations, biorepositories, academic institutions, and government labs.

Product overview

Genemod offers an Agentic Lab OS combining AI-powered LIMS (Laboratory Information Management System) and ELN (Electronic Lab Notebook) in one unified platform. The core portfolio includes AI LIMS, AI ELN, and AI Agent products, supplemented by AI features (Global Search, Sample Tracking, Protocol Template, Data Migration, Data Security, AI-Driven Workflows) all powered by the Genemod AI platform using GPT. Additional platform components include inventory management tools (Virtual Freezers/Sample Management, Lineage, Lab Consumables, Orders, Alerts), notebook features (Experiments, Lab Protocol, Version Control, Reports), and platform infrastructure (Security, Integrations, Equipment). The system is designed for regulated labs managing 10M+ records with built-in audit trails, compliance features, and cloud-based architecture for biopharma R&D teams.

Differentiator

Problem solved

Functional benefit

Products and services

  • AI LIMS AI-powered Laboratory Information Management System that transforms lab operations, streamlines workflows, and accelerates scientific discovery through integrated inventory, sample, and equipment management. Used by biopharma R&D teams, biotech startups, clinical research, biorepositories, and academic labs.
  • AI ELN AI-powered Electronic Lab Notebook with GPT integration for streamlined data access, enhanced research report quality, and experimental process optimization. Used by life sciences researchers and lab teams to capture and collaborate on experiments.
  • AI Agent Natural language AI agent that executes real, audit-logged actions across inventory and notebooks through conversational commands, covering sample registration (10x faster than manual), transfers, documentation, and protocol management. Targeted at regulated labs running complex multi-step operations.
  • Genemod AI Platform Core AI platform powering all Genemod AI features, enabling GPT-based assistance within the LIMS/ELN environment for search, sample tracking, protocol templating, data migration, security, and AI-driven workflows.

Quantifiable outcome

  • 10x faster sample registration vs. manual click-through
  • +2 more outcomes

Companies that use Genemod

Customer profile

Named customers15 records

Segments9 records

Ideal customer profiles4 records

Genemod technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability9 records

Feature5 records

Genemod partnerships and signals

Strategic signal

Scale indicators2 records

Recent moves6 records

Expansion highlights6 records

Genemod competitors and assessment

Company assessment

Direct peers

  • Benchling: Benchling is the leading cloud-native ELN and R&D platform for life sciences, directly competing with Genemod's AI LIMS and AI ELN products. Both target biopharma R&D teams with unified data models, audit trails, and AI-assisted workflows, making it Genemod's most direct competitor.
  • LabArchives: LabArchives is a widely adopted electronic lab notebook used across academia and industry. Genemod explicitly publishes a 'LabArchives vs Genemod' comparison page, confirming it as a direct competitor for ELN and lab data management in research labs.
  • Quartzy: Quartzy is a lab inventory and order management platform that overlaps with Genemod's inventory, consumables, and order-tracking modules. Genemod publishes a 'Quartzy vs Genemod' comparison page, indicating direct competition for lab operations workflows.
  • Dotmatics: Dotmatics (now part of Siemens) provides a scientific R&D platform with ELN, LIMS, and inventory capabilities targeting biopharma. It competes directly with Genemod across the same primary customer segments and core product modules.
  • IDBS (Danaher): IDBS offers the Polar and E-WorkBook ELN/LIMS platforms widely used in biopharma R&D and bioprocess development. It is a direct peer serving the same biopharma, industrial biotech, and CDMO customers that Genemod targets.
  • Sapio Sciences: Sapio Sciences provides a unified LIMS, ELN, and scientific data management platform with growing AI capabilities. It serves biopharma and diagnostics customers comparable to Genemod's primary segments, with similar emphasis on regulated environments.
  • LabVantage Solutions: LabVantage is an enterprise LIMS platform with ELN extensions used by pharma, biobanks, and manufacturing. It competes for the same regulated lab data management budget as Genemod, particularly in biomanufacturing and biorepository use cases.
  • FreezerPro (Brooks Life Sciences): FreezerPro is a sample and freezer management solution used by biobanks and research labs. Genemod publishes a 'FreezerPro vs Genemod' comparison page, indicating direct overlap in virtual freezer, sample, and inventory workflows.

Broad incumbents

  • Revvity Signals (formerly PerkinElmer Informatics): Revvity Signals offers the TIBCO Spotfire and Signals Notebook/Notebook+ products covering ELN, LIMS, and analytics for pharma and life sciences. It is a broad incumbent with overlapping capabilities rather than a niche specialist like Genemod.
  • STARLIMS (Abbott): STARLIMS is a long-standing LIMS platform used across clinical, manufacturing, and life sciences labs. It competes in the broader LIMS category but is a generalist incumbent rather than an AI-native, life-sciences-focused platform like Genemod.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights4 records

Customer concentration

Genemod social profiles

Digital presence

Genemod compliance and trust

Trust signal

Compliance3 records

Genemod financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Genemod leadership team

Management profile

Number of profiles

Profiles2 records

Genemod funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors12 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Genemod M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Genemod

What does Genemod do?

Genemod provides an AI-powered cloud-based Lab OS that unifies an Electronic Lab Notebook (ELN) and a Laboratory Information Management System (LIMS) into a single platform for life sciences R&D teams. The product covers inventory and sample management, experiment and protocol documentation, order tracking, alerts, and equipment management, augmented by an agentic AI layer that executes real, audit-logged lab operations via natural language. It is sold as a SaaS subscription to pharmaceutical companies, biotech firms, clinical research organizations, biorepositories, academic institutions, and government labs.

Is Genemod a public or private company?

Genemod is a private company. It is classified as venture growth investor backed and is currently operating.

When was Genemod founded?

Genemod was founded in 2023. It employs 1 to 10 people.

Where is Genemod based?

Genemod is headquartered in Seattle, United States, in the North America region.

How does Genemod make money?

One revenue line is on record: saaS Subscription.

Who are Genemod's main competitors?

Direct peers on record are Benchling, LabArchives, Quartzy, Dotmatics, IDBS (Danaher), Sapio Sciences, LabVantage Solutions and FreezerPro (Brooks Life Sciences). Broad incumbents are Revvity Signals (formerly PerkinElmer Informatics) and STARLIMS (Abbott).

Does Genemod have an API?

No public API is recorded for Genemod.

What industry is Genemod in?

Genemod's product category is Lab Information Management and Electronic Lab Notebook Software. Its primary akta.pro industry code is HLAGAIAF, Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays), with a secondary code of HLAAAIAD, Synthetic Biology & Genetic Circuit Design Platforms (pathway engineering, chassis development). Its NAICS code is 5417 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Pulse 2.0Genemod: $4.5 Million Secured For Workspace Collaboration PlatformGenemod raised $4.5 million in seed funding co-led by defy.vc and LDV Partners. The cloud-based workspace collaboration platform expanded into biopharma R&D, working with companies like AstraZeneca, Bristol-Myers, and Merck. The funding supports its platform for managing the R&D lifecycle and addressing the reproducibility crisis.HIT ConsultantGenemod Raises $4.5M to Expand Central Research Platform for Biopharma CompaniesGenemod raised $4.5 million in seed funding co-led by defy.vc and LDV Partners. The company provides a cloud-based workspace for biopharma R&D teams, digitizing data capture and workflows. It has expanded into the biopharma space, working with teams from AstraZeneca, Bristol-Myers, and Merck.PR NewswireGenemod raises $4.5M to become the central research platform for biopharma companiesGenemod has successfully raised $4.5 million in seed funding, co-led by defy.vc and LDV Partners, to enhance its cloud-based research platform for biopharma companies. The funding will support Genemod's mission to address inefficiencies in biopharma R&D and improve research collaboration among teams. The company aims to become the standard tool for research scientists, similar to how Figma is used by designers.VC News DailyGenemod Lands $4.5M Seed RoundGenemod announced the closure of a $4.5 million seed funding round co-led by defy.vc and LDV Partners, with participation from Dolby Family Ventures and Vulcan/Cercano Ventures. The startup develops cloud-based workspace collaboration software specifically designed for biopharma R&D teams to improve productivity in hybrid work environments.PR NewswireGenemod Raises $1.7M in Oversubscribed Seed Round to Drive the Next Generation of MedicineGenemod, a Seattle-based software company providing cloud-based solutions for life scientists, announced a $1.7 million oversubscribed seed funding round led by Defy.vc with participation from Omicron, Unpopular Ventures, Underdog Labs, and Canaan Partners Scout Fund. The funding will enable Genemod to expand its product offerings to include complimentary product management software alongside its flagship life sciences inventory management service, grow its workforce by 50 percent, and extend its customer base from academic institutions into small biotech enterprises.TechCrunchGenemod raises cash for its lab inventory management service used by research institutions around the USGenemod raised $1.7 million in seed funding from Defy.vc and other investors. The company will use the capital to develop product management software to complement its lab inventory management service. Defy.vc will serve as a growth partner, with Neil Sequeira joining the board.